Man Li

1k citations
53 papers · 771 · 1 hit paper · h-index 15

Impact in

    • Breast Cancer Treatment Studies
    • Cancer Immunotherapy and Biomarkers
    • Cancer Cells and Metastasis

Papers in

    • Breast Cancer Treatment Studies 10
    • HER2/EGFR in Cancer Research 6
    • Cancer Cells and Metastasis 3
    • Cancer Immunotherapy and Biomarkers 2

Man Li

50 papers receiving 761 citations

Man Li's Hit Papers

Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial 2024 · 97 citations
970+1Years since publication255075

Peers

Man Li
Comparison fields: 5 of 71
  • Cancer Research 121
  • Oncology 167
  • Pulmonary and Respiratory Medicine 146
  • Cell Biology 49
  • Molecular Biology 215
Replace Xingling Zheng with:
Xingling Zheng China
Sara Mainardi Netherlands
Marta Llauradó Canada
Michael M. Lizardo United States
Nicoletta Cordani Italy
Xuebing Di China
Luís Palomero Spain
Sonia H.Y. Kung Canada
Yeonjoo Jung South Korea
Man Li relative to Xingling Zheng China Xingling Zheng's profile →
Citations per field
00.5×2×2.6×
Xingling Zheng · 1×
Citations per year

Countries citing papers authored by Man Li

Since Specialization
Citations

This map shows the geographic impact of Man Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Man Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Man Li more than expected).

Fields of papers citing papers by Man Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Man Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Man Li. The network helps show where Man Li may publish in the future.

Co-authors

The 25 scholars most cited alongside Man Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Man Li Line = papers co-authored together Man Li links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial
Hit paper breakdown →
202497
2 202089
3 201163
4 201956
5 202044
6 201735
7 201632
8 201632
9 202124
10 201522
11 201219
12 202019
13 201716
14 201916
15 202115
16 201414
17 202414
18 202011
19 202211
20 20199

About Man Li

Man Li is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism, having authored 53 papers that have together received 771 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (10 papers), HER2/EGFR in Cancer Research (6 papers), Advanced Breast Cancer Therapies (4 papers), Cancer Cells and Metastasis (3 papers), Lung Cancer Treatments and Mutations (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Extracellular vesicles in disease (2 papers) and BRCA gene mutations in cancer (2 papers). The work is most often cited by research in Cancer Research (121 citations), Oncology (167 citations), Pulmonary and Respiratory Medicine (146 citations), Cell Biology (49 citations) and Molecular Biology (215 citations). Man Li has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Zuowei Zhao, Xuelu Li, Lingzhi Xu, Chen Song, Huiming Yuan, Lihua Zhang, Lijuan Zou, Qi Wu, Yukui Zhang and Zhen Liang. Their work appears in journals such as Therapeutic Advances in Medical Oncology, Cell Death and Disease, Biochemical Genetics, Molecular Carcinogenesis and The Breast.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact